Search Results 1511-1520 of 18674 for Relapse

  1. Medical Research & Education - Mayo Clinic News Network

    Mayo researchers correlate specific antibody with relapse of neurological disorder featured image · COPD / sepsis / advances in human genome research: Mayo ...

  2. Study of LNP023 (iptacopan) in patients with ANCA-associated vasculitis - Mayo Clinic

    Newly diagnosed or relapsed GPA and MPA (according to the 2022 ACR/EULAR classification criteria for GPA and MPA) requiring treatment with RTX and GC as per ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...

  4. Sharing Mayo Clinic: Hope with new treatment in a clinical trial

    ... relapsed multiple myeloma. "While there are multiple immunotherapy options approved by the FDA for the treatment of multiple myeloma, we do not know how to ...

  5. A Study To Assess The Feasibility And Safety Of Intratumoral Diffusing Alpha Emitters For The Treatment Of Recurrent Glioblastoma - Mayo Clinic

    More than 3 relapses per RANO criteria. Acquired and or genetic clinical bleeding tendency. Suspicious of infratentorial or leptomeningeal or intraventricular ...

  6. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    ... relapsed/progressed while on or within 1 month from completion of adjuvant chemotherapy Phase 1: Up to 3 lines of prior chemotherapy are allowed Phase 2: Up ...

  7. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    New or relapsed GPA or MPA that require treatment with CYC or RTX plus GCs. Exclusion Criteria: Any other multisystem autoimmune disease. Requires ...

  8. Drug Combo Shuts Down Stem Cells, Tumor Growth in Lung Cancer - Mayo Clinic News Network

    “Then, once therapy is stopped, these cancer stem cells can re-establish the tumor and cause a relapse.” The current research study built upon previous ...

  9. A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene - Mayo Clinic

    Patients with relapsed /refractory AML, ALL, or MLL with rearrangement of the MLL gene, including 11q23 or PTD, are eligible for the expanded cohort: At ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...